Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB01101_nanopub.RAYTGx-sYd3LMp9qkvrLT2IZ8XqJGJga8doyfsWOpaEDE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB01101 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB01101 label "DDI between Trimethoprim and Capecitabine - The strong CYP2C9 inhibitor, Capecitabine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Capecitabine is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB01101]" assertion.
- drugbank_resource:DB00440_DB01101 identifier "drugbank_resource:DB00440_DB01101" assertion.
- drugbank_resource:DB00440_DB01101 title "DDI between Trimethoprim and Capecitabine - The strong CYP2C9 inhibitor, Capecitabine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Capecitabine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB01101 assertion.
- drugbank:DB01101 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB01101 assertion.